drugset
drugset / Trial / NCT05284890

A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants

NCT05284890 ↗

Phase 1 Completed 8 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to characterize the absorption, distribution, metabolism and excretion (ADME) of a single oral dose of \[14C\] CC-99677.

Timeline

Start
2022-05-12
Primary completion
2022-07-11
Completion
2022-07-11

Drugs

EvaluationDrugModalityDoseRoute
Subject GAMCEMETINIB Small molecule — Oral

Indications

No indication recorded.